HEALEY ALS Platform Trial Research Partners
Pioneering Breakthroughs Together
Collaboration is the key to our success. We believe sharing knowledge and expertise are essential to rapidly bringing innovative therapies to patients. That’s why we are partnering with leading academic institutions, global leaders in research and the entire ALS community to launch the first platform trial for ALS. We, in turn, are pleased to share our collective learnings with our peers to accelerate therapeutic innovation.
Academic Partnerships
Mass General Biostatitics Center
Barrow Neurological Institute
Northeast ALS Consortium (NEALS)
University of Rochester
Berry ConsultantsIndustry Partnerships
Biohaven Pharmaceuticals
Clene Nanomedicine
Implicit Bioscience
Prilenia Therapeutics
Ra PharmaceuticalsOur commitment to advancing treatment and therapies for individuals with ALS encourages us to the constant pursuit of new research partnerships and collaborations. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!
Investigator Resources
Learn more ways to partner with us in the collaborative HEALEY ALS Platform Trial.HEALEY ALS Platform Trial Publication Policy
HEALEY ALS Platform Trial Ancillary Study Policy
Join Our Quest
Join these people and organizations in supporting our quest to find a cure for ALS.